18,101 Shares in First Trust Nasdaq Pharmaceuticals ETF $FTXH Purchased by Englebert Financial Advisers LLC

Englebert Financial Advisers LLC purchased a new position in shares of First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 18,101 shares of the company’s stock, valued at approximately $751,000. Englebert Financial Advisers LLC owned 0.07% of First Trust Nasdaq Pharmaceuticals ETF as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also made changes to their positions in FTXH. Cyndeo Wealth Partners LLC acquired a new position in First Trust Nasdaq Pharmaceuticals ETF in the 3rd quarter valued at approximately $1,524,000. Trust Co. of Oklahoma purchased a new position in shares of First Trust Nasdaq Pharmaceuticals ETF during the 3rd quarter valued at $1,283,000. Nilsine Partners LLC grew its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 3.5% during the 2nd quarter. Nilsine Partners LLC now owns 28,057 shares of the company’s stock valued at $1,071,000 after acquiring an additional 937 shares in the last quarter. MinichMacGregor Wealth Management LLC purchased a new position in shares of First Trust Nasdaq Pharmaceuticals ETF during the 3rd quarter valued at $968,000. Finally, Vivaldi Capital Management LP grew its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 16.0% during the 1st quarter. Vivaldi Capital Management LP now owns 12,590 shares of the company’s stock valued at $433,000 after acquiring an additional 1,741 shares in the last quarter.

First Trust Nasdaq Pharmaceuticals ETF Trading Up 2.7%

NASDAQ FTXH opened at $42.70 on Wednesday. First Trust Nasdaq Pharmaceuticals ETF has a 1-year low of $29.25 and a 1-year high of $43.52. The firm’s fifty day simple moving average is $41.30 and its 200-day simple moving average is $37.98. The company has a market capitalization of $1.13 billion, a PE ratio of 14.51 and a beta of 0.45.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Shareholders of record on Thursday, September 24th were paid a $0.0113 dividend. This represents a $0.05 dividend on an annualized basis and a yield of 0.1%. This is a decrease from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.0920. The ex-dividend date was Thursday, September 24th.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.